3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
22
Gynecologic
4
Genitourinary
4
Breast
4
Head & Neck
2
Tumor-Agnostic
1
Sarcoma
1
Other solid neoplasm
1
Gastrointestinal
1
CNS
1
Conditions
Mesothelioma
1
Interventions
Nivolumab
3
Ipilimumab
3
pembrolizumab
2
entrectinib
2
cobimetinib
2
Pemetrexed
2
Cisplatin
2
tovorafenib
1
sotorasib
1
relatlimab
1
pralsetinib
1
larotrectinib
1
ipatasertib
1
inavolisib
1
daratumumab
1
atezolizumab
1
alectinib
1
PM 01183
1
Midazolam
1
Carboplatin
1
Ado-Trastuzumab Emtansine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has announcements
×
Carboplatin
×
Other solid neoplasm
×
Clear all
NCT02899299
2024-05-21
CheckMate743
Bristol-Myers Squibb
Phase 3
Completed
605 enrolled
17 charts
1 FDA